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Abstract
Recent studies suggest that schizophrenia (SCH) and bipolar disorder (BPD) may share a similar etiopathology. However,
their precise neuropathological natures have rarely been characterized in a comprehensive and quantitative fashion. We
have recently developed a rapid, quantitative cell-counting method for frozen unfixed postmortem brains using a flow
cytometer. In the present study, we not only counted stained nuclei, but also measured their sizes in the gray matter of
frontopolar cortices (FPCs) and inferior temporal cortices (ITCs) from patients with SCH or BPD, as well as in that from
normal controls. In terms of NeuN(+) neuronal nuclei size, particularly in the reduced densities of small NeuN(+) nuclei, we
found abnormal distributions present in the ITC gray matter of both patient groups. These same abnormalities were also
found in the FPCs of SCH patients, whereas in the FPCs of BPD patients, a reduction in oligodendrocyte lineage (olig2(+))
cells was much more common. Surprisingly, in the SCH FPC, normal left-greater-than-right asymmetry in neural nuclei
densities was almost completely reversed. In the BPD FPC, this asymmetry, though not obvious, differed significantly from
that in the SCH FPC. These findings indicate that while similar neuropathological abnormalities are shared by patients with
SCH or BPD, differences also exist, mainly in the FPC, which may at least partially explain the differences observed in many
aspects in these disorders.
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Introduction
The similarities and differences between schizophrenia (SCH) and
bipolardisorder(BPD)havelongbeenofinterestamongawiderange
of research fields in psychiatry. Recent epidemiological and genetic
findings suggest that SCH and BPD have certain common etiological
factors, or share several chromosomal loci and genes, which may
confer vulnerability to these disorders [1-3]. In neuroimaging studies,
however, the results have proven somewhat mixed. For example, the
most consistent gross anatomical changes found in SCH include
lateral and third ventricular enlargement, medial temporal lobe
volume reduction, and superior temporal cortex volume reduction,
particularly on the left side [4]. In BPD, however, mild ventricular
enlargement and the presence of white matter hyper-intensities
remain among the most consistently reported abnormalities [5].Such
evidence gives rise to several important questions regarding
psychiatric neuropathology: (i) To what extent do the phenotypic
expressions of these disorders overlap? (ii) Where and how do these
disorders diverge? (iii) What are the neuropathological changes
associated with these gross anatomical abnormalities?
Although a few definitive quantitative neuropathological
findings for either SCH and/or BPD have been described with
regards to the temporal cortex, several histopathological studies
examining the prefrontal cortex have consistently reported the
potential role of interneurons in the pathophysiology of SCH and
BPD. For example, using Nissl-stained sections, Benes et al [6].
were the first to provide evidence that SCH patients had reduced
numbers of small non-pyramidal interneurons in layers I and II, as
well as increased numbers of pyramidal neurons in layer V of the
frontopolar cortex (FPC; BA 10), without any concomitant total
neuronal loss. Subsequent studies of the SCH prefrontal cortex
have almost consistently supported their results, demonstrating the
presence of reduced gene expression levels for the 67 kDa isoform
of glutamic acid decarboxylase (GAD67) [6-11], gamma-amino-
butyric acid (GABA) membrane transporter 1 [12], reelin [8,9,11],
and parvalbumin [10], as well as lower densities of neurons
positive for GAD67 [13], parvalbumin [14], reelin [8], or
calbindin [15]. Furthermore, some of these alterations were also
observed in the BPD (and in some cases of affective psychosis)
prefrontal cortex [6,8,13,15].
Recently, we developed a novel flow cytometeric (FCM) cell-
counting method to quantify the densities and fluorescent
intensities not only of neural cell nuclei labeled for DNA (total),
but also of the neuronal and oligodendroglial nuclear markers,
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postmortem brains [16]. In the present study, we applied this
method to investigate the neuropathological similarities and
differences in the gray matter of the FPC and ITC from patients
with SCH or BPD, as well as from normal controls. Furthermore,
while taking the utmost care for osmotic control, we measured
nuclear size, which was particularly important in distinguishing
those small NeuN(+) nuclei that roughly represent small non-
pyramidal interneurons.
Results
FCM measurement of nuclei densities
We first quantified gray matter nuclei densities of frozen
postmortem FPCs and ITCs from patients with BPD (FPC,
n=12; ITC, n=11) and SCH (FPC, n=10; ITC, n=11), as well
as from normal controls (FPC, n=12; ITC, n=12) obtained
from the Stanley Foundation Neuropathological Consortium
(Table S1). We found a significant decrease in the densities of 7-
AAD(+) (total) nuclei in the FPCs of BPD subjects (216%,
P=0.038), but not in SCH patients (P=0.118) (Fig. 1a). No
significant differences were found in the densities of NeuN(+)a n d
NeuN(2)/olig2(2) nuclei in the FPCs of either group, nor in
those containing total (7-AAD(+)), NeuN(+), olig2(+) and
NeuN(2)/olig2(2) nuclei in the ITC of control versus BPD or
SCH patients (Figure 1b,d,e-h).
A significant group difference was found in the densities of
olig2(+) nuclei in the FPCs of BPD patients (240%, P=0.018)
(Figure 1c). In a subgroup of BPD FPC samples, in which two
peaks of olig2(+) populations could be clearly measured (9 control,
9 BPD), significant decreases were also found in the densities of
both olig2
strong(+)( 228%, P=0.034) and olig2
weak(+) nuclei
(253%, P=0.008) (Figure 2), suggesting that oligodendroglial
reductions in the BPD FPC may stem from decreased levels of
OPCs (olig2
strong(+)) and OLs (olig2
weak(+)), as was observed in the
FPC from subjects with MDD [16].
Validation of forward scatter (FS) values as nuclei size
Forward scatter (FS) values (FS 0-1023) are generally associated
with particle size in the context of FCM measurements [17]. It our
experimental settings, however, it was unclear whether the FS
values we obtained really represented nuclei size. We therefore
first examined the appearance and stability of the isolated nuclei
from frozen unfixed postmortem brains. In our experimental
procedure, the osmotic pressures of nuclei suspensions were kept
within the physiological range (280 , 290 mOsm), except for the
isolation process in which lysis buffer with ,375 mOsm was used
in order to protect nuclei from mechanical homogenization.
Figure 3A shows the typical appearance of isolated human nuclei
in PBS stained with NeuN or olig2. We found no leakage of DNA
Figure 1. Densities of nuclei in 1 mg of gray matter tissue. (a-d) FPC and (e-h) ITC. (a, e) 7-AAD(+), (b, f) NeuN(+), (c, g) olig2(+), and (d, h)
NeuN(2)/olig2(2) nuclei. *P,0.05 by unpaired t-test.
Figure 2. Densities of olig2
weak(+) and olig2
strong(+) nuclei in
1 mg of gray matter tissue from BPD FPC. (A) olig2
weak(+), and
(B) olig2
strong(+) nuclei. *P,0.05 by unpaired t-test.
doi:10.1371/journal.pone.0033019.g002
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suggesting that the nuclear envelopes were well preserved in our
isolation and staining processes. This was further supported by the
FCM measurement of 7-AAD(+) nuclei, in which 7-AAD(+) nuclei
were clearly aligned on the two horizontal lines with almost
uniform florescent intensities (Figure 3B, arrows, the thin upper
line is probably composed of nuclei in the G2 and M phases of the
cell cycle), suggesting that full DNA components (sometimes
double amounts of DNA) are stably preserved in the nuclei even
during FCM measurement. We also examined the temporal
stability of FS values. No difference was found in the distribution
of FS values for any of the stained nuclei between 4 and 18 hours
after homogenization (Figure 3C, NeuN), suggesting that the FS
values of isolated nuclei were quite stable, at least during the
experimental period.
We then compared the distribution patterns between FS values
and nuclear size, measuring them microscopically (Figure S1). We
found that the distribution of FS values of NeuN(+) nuclei almost
matched NeuN(+) nuclei size (Figure 3D), suggesting that the FS
values actually represent nuclear size. However, we noted that the
isolation of large NeuN(+) nuclei (FS 400 $) remained incomplete,
allowing NeuN(+) perinuclear structures to attach themselves
around the true border of the nuclei (Figure 3E; for a more
detailed view, see Figure S1c). Furthermore, preliminary animal
studies revealed that PMIs (but not gender or storage period)
significantly increased the FS values of NeuN(+) nuclei in a time-
dependent manner, albeit without changing the total numbers of
NeuN(+) nuclei or the peak heights of the NeuN(+) nuclei
distribution pattern (Figure S2). These findings suggest that while
the FS values of small NeuN(+) nuclei represent, in a relatively
reliable fashion, nuclei size, those of large NeuN(+) nuclei (FS 400
$) may be inaccurate. We therefore excluded large NeuN(+)
nuclei (FS 400 $) from further analyses in our human postmortem
brain studies.
FCM measurement of NeuN(+) nuclei size
In the distribution of FS values for the adjusted population
(10,000) of olig2(+) and NeuN(2)/olig2(2) nuclei, no significant
group difference was noted in either brain region. In contrast, a
significant group difference was detected in the FS distribution of
NeuN(+) nuclei. We found that the distribution of small NeuN(+)
nuclei (especially the numbers of NeuN(+) nuclei with FS values of
200 – 300) had decreased in both brain regions of SCH patients
(Figure 4, Table S2). In BPD subjects, however, while the
distribution of small NeuN(+) nuclei in the ITC was also
significantly lower, no major difference was found in the FPC
(Figure 4, Table S2).
Effects of confounding factors on nuclei counts
To examine the effects of confounding factors, we first
performed Pearson’s correlations between the nuclei counts and
countable confounding factors. Significant positive correlations
were found in some confounding factors with the NeuN(+),
olig2(+), or NeuN(2)/olig2(2) nuclei densities (Table S3). Thus,
ANCOVA was performed using these variables as covariates and
no change was noted regarding the main effects of the densities of
NeuN(+) (FPC; BPD, P=0.508, SCH, P=0.112), olig2(+) (FPC;
BPD, P=0.013, SCH, P=0.072; ITC; BPD, P=0.843, SCH,
P=0.305), or NeuN(2)/olig2(2) nuclei (ITC; BPD, P=0.179,
SCH, P=0.183), nor was any recorded with the other nuclei.
Certain countable confounding factors such as age at onset,
duration of disease, and fluphenazine equivalent were analyzed
separately with only the diseased groups (Table S4). In the FPC,
we found a significant positive correlation between duration of
disease and total, NeuN(+), or NeuN(2)/olig2(2) nuclei densities.
Since reduced gray matter volume has also been reported in the
prefrontal areas of BPD [18] and SCH [19], and is often
negatively correlated with the duration of disease [19], these
positive correlations in the FPC may be explained in part by the
reduced gray matter volumes of the FPC, the result of longer
disease durations, although there is no concomitant loss of
NeuN(+) and NeuN(2)/olig2(2) cells.
Both the postmortem interval (PMI) and the refrigeration
interval were significantly longer in the SCH group (Table S1). We
therefore excluded some samples with extremely long PMIs (, 40
hrs) and refrigeration intervals (, 20 hrs) in order to better match
these variables. We then reanalyzed the rest of the samples and
obtained essentially the same results as regards the nuclei densities
(Table S5) and the NeuN(+) nuclei distribution patterns (Table S6).
Figure 3. Validation of forward scatter (FS) values of nuclei
isolated from frozen unfixed human postmortem brains. (A)
Appearance of a human NeuN(+) (upper) or olig2(+) nucleus (lower) in
PBS (280 mOsm). Scale bar, 20 mm. (B) FCM measurement of 7-AAD(+)
nuclei. Arrows indicate two major populations of 7-AAD(+) nuclei. (C)
Stability of isolated NeuN(+) nuclei in PBS. No difference was found in the
FS distributions of NeuN(+) nuclei analyzed at 4 h and 18 h after
homogenization, suggesting that the size of NeuN(+) nuclei remained
quitestableinPBS.(D)Distributionof7-AAD(+) (red)andNeuN(+) (green)
nuclei areas (m m
2) as determined by microscopic measurements. The
nuclei populations were delineated every 50 mm
2. (E) Correlation
between the areas of 7-AAD(+) and NeuN(+) nuclei (m m
2) as measured
microscopically. The arrow (200 mm
2 of NeuN(+) area) indicates a point
that corresponds approximately to FS 400. Beginning with this point, the
area of the NeuN(+) nuclei became gradually larger than that of the 7-
AAD(+) nuclei, although the areas of the 7-AAD(+) and NeuN(+) nuclei
correlated to a significant degree (r=0.917, P,0.001).
doi:10.1371/journal.pone.0033019.g003
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hemisphere, gender, and severity of alcohol and/or substance
abuse. We found that abnormalities in the densities of 7-AAD(+)
and olig2(+) nuclei in BPD and SCH FPCs were more pronounced
in the left hemispheres (Table S7). On the other hand, no such
effects were found in the ITCs of BPD and SCH patients (Table
S8).
Interestingly, in the control FPC, the left hemispheres tended to
have increased densities of nuclei compared to the right
hemispheres (Figure 5). Furthermore, these normal left-greater-
than-right asymmetries were almost completely reversed in SCH
subjects. Two-factor factorial ANOVA (diagnostic group6brain
hemisphere) revealed significant group differences between control
and SCH in the densities of 7-AAD(+) (F(1,18)=8.93, P=0.008),
NeuN(+) (F(1,18)=6.97, P=0.017), NeuN(2)/olig2(2)
(F(1,18)=10.13, P=0.005), but not in olig2 nuclei densities. In
contrast, no significant group difference was found between
control and BPD groups; rather, BPD differed from SCH in the 7-
AAD (F(1,18)=4.72, P=0.043) and NeuN(+) nuclei densities
(F(1,18)=4.78, P=0.042). In the ITC samples, no such clear left-
right asymmetries or reversals in SCH patients were observed.
Discussion
The present study applied a novel flow cytometric cell-counting
method for frozen unfixed postmortem brain tissue as a means of
Figure 4. Distribution of FS values of NeuN(+) nuclei (10,000 nuclei) in the gray matter tissue. (A) FPC, (B) ITC, (a) Abnormal distributions
of FS values of NeuN(+) nuclei. (b) Abnormal reductions of the small NeuN(+) nuclei counts (FS 200 – 300) in SCH and BPD. * P,0.05, **P,0.01,
unpaired t-test. mean6s.e.m.
doi:10.1371/journal.pone.0033019.g004
Figure 5. Asymmetry of the nuclei densities in the FPC. (A) 7-
AAD(+), (B) NeuN(+), (C) olig2(+), and (D) NeuN(2)/olig2(2) nuclei. Left-
right asymmetry rates (%) were calculated using the following formula:
(the mean nuclei density in the left hemisphere)/(the mean nuclei
density in the right hemisphere)6100–100 (%). The positive % indicates
left-greater-than-right asymmetry in the nuclei densities and the
negative % vice versa. * P,0.05, **P,0.01, two-factor factorial ANOVA
(diagnostic group6brain hemisphere).
doi:10.1371/journal.pone.0033019.g005
A Postmortem Brain Study for Psychiatric Disorders
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33019investigating the neuropathological similarities and differences
between SCH and BPD. While taking the utmost care for osmotic
control, we measured the densities, fluorescence intensities, and FS
values (sizes) of total (7-AAD(+)), neuronal (NeuN(+)), and
oligodendroglial (olig2(+)) cell nuclei, as well as other neural cell
(NeuN(2)/olig2(2)) nuclei in the gray matter of FPCs and ITCs
from patients with either SCH or BPD, and from normal controls.
We found that i) in the ITC, there exist abnormal reductions in the
densities of small NeuN(+) nuclei, without a concomitant loss of
total NeuN(+) nuclei densities, in both SCH and BPD; ii) in the
FPC, by contrast, SCH was characterized primarily by the same
abnormality noted in the densities of small NeuN(+) nuclei,
whereas BPD was characterized by reductions in the densities of
olig2(+) nuclei; iii) the normal left-greater-than-right asymmetry
observed in the nuclei densities of control FPCs was almost
completely reversed in those of SCH FPCs, albeit to a lesser extent
than those of BPD FPCs; and iv) in terms of the 7-AAD(+) and
NeuN(+) nuclei density asymmetries recorded in the FPC, there
was a statistically significant group difference between SCH and
BPD patients.
Abnormalities in the inferior temporal cortex (BA20)
The densities of small NeuN(+) nuclei in the gray matter of
ITC were abnormally reduced in both SCH and BPD patients
without any concomitant loss of total NeuN(+) nuclei densities.
To our knowledge, this is the first quantitative neuropathological
study of the ITC from subjects with psychiatric disorders,
suggesting that the densities of neurons with small NeuN(+)
nuclei may be lower in the ITC of subjects with SCH or BPD.
Since a high degree of correlation exists between nuclei size and
perikaryon volume in neocortical neurons [20], small NeuN(+)
nuclei may, in fact, be small non-pyramidal interneurons. There
are reports of interneuronal abnormalities in widespread regions
of SCH and/or BPD brains, including the dorsolateral
prefrontal (DLPFC, BA9) [7,8,10,12], anterior cingulate (ACC,
BA24) [10,13,15], primary motor, and visual cortices [10], as
well as in the hippocampus [9]. Our findings herein support,
albeit in a different way, the following conclusions: i) in the SCH
and BPD ITC, similar reductions in neurons with small NeuN(+)
nuclei, which most likely are interneurons, were present; and ii)
lower densities of small NeuN(+) neurons appeared to be
compensated for by insignificant increases in the densities of
large NeuN(+) neurons, without concomitant reductions of total
NeuN(+)n e u r o n s .
Recent neuroimaging studies have shown that bilaterally
smaller ITC volumes and/or cortical thinning are present in
first-episode (as well as chronic) SCH and/or first-episode affective
psychosis [21,22], suggesting that certain neuropathological
abnormalities exist in the ITC at the onset of illness, possibly
even long before the onset. Our findings support this hypothesis,
albeit in a different manner, and suggest that abnormally reduced
small NeuN(+) neurons may constitute one of the neuropatholog-
ical correlates associated with such neuroimaging abnormalities.
Because the abnormal distribution pattern of small NeuN(+) nuclei
in SCH differed slightly from that of BPD (Figure 4Ba), future
studies will need to utilize different nuclear markers for
interneurons, such as calcium-binding proteins and/or transcrip-
tion factors, in order to more effectively distinguish the subtypes of
interneurons and to more clearly characterize the neuropatholog-
ical similarities and differences between SCH and BPD.
Abnormalities in the frontopolar cortex (BA10)
In the SCH FPC, although not in the BPD FPC, we detected
abnormal reductions in the densities of small NeuN(+) nuclei
without any concomitant decrease in total NeuN(+) nuclei
densities. Previous neuropathological studies of fixed brains have
demonstrated similar neuronal abnormalities in the SCH FPC,
albeit in different layers; i.e., reduced numbers (or densities) of
small Nissl-stained neurons in layers I and II [6], parvalbumin-
immunoreactive neurons in layers III and IV [14], and reelin-
immunoreactive neurons in layers I, II, and IV [11]. Although our
data does not address lamina formation, our findings are quite
similar to those reported by Benes et al. [6], who, uniquely,
utilized a vibratome instead of conventional paraffin sectioning for
cutting the tissues. This was done in order to avoid the
approximate 30% tissue shrinkage that occurs as a result of
alcohol and xylene treatment during the paraffin-embedding
process [6].
In the BPD FPC, in contrast, we observed reductions primarily
in the densities of olig2(+) nuclei. Similar oligodendroglial
abnormalities were also found in the FPC from subjects with
major depressive disorder (MDD) [16], suggesting that cortical
oligodendroglial abnormalities in the FPC, such as deficits in the
proliferation and maturation of oligodendrocyte lineage (olig2(+))
cells, may represent a neuropathology common to various mood
disorders. Interestingly, adulthood cortical myelination, an
essential process for establishing an efficient neuronal network in
the cortex [23], continues at least until the fifth decade in the FPC
[24]. Further supporting our findings, myelin basic protein
expression was reduced in the postmortem FPC of patients
suffering from mood disorders, but not in those with SCH [25]. In
neuroimaging studies, the presence of hyper-intensities is among
the most consistently reported abnormality, not only in BPD but
also in MDD brains [5,26]. Future studies will be required to
determine whether or not such oligodendroglial abnormalities are
specific to mood disorders, or if they are common to psychiatric
disorders in general, and simply exist to a greater extent in mood
disorders than in SCH.
The FPC is the single largest architectonic region in the
prefrontal cortex (PFC) that is almost exclusively connected to the
more posterior supramodal areas such as the DLPFC and the
orbitofrontal cortex [27]. Recent functional neuroimaging studies
have revealed that the FPC probably plays roles in overcoming the
limitations of more posterior prefrontal processes–such as working
memory in the DLPFC [28], and decision making and hedonic
processes in the OFC [29]–by enabling the emergence of more
flexible, long-lasting, and possibly more rewarding cognitive
control mechanisms as a human being seeks optimal social
behavior [30].
Hemispheric abnormalities in the frontopolar cortex (BA
10)
In the FPCs of control cases we found that the densities of nuclei
in the left hemispheres were greater than those in the right
hemispheres. Interestingly, in SCH FPCs, such asymmetries were
almost completely reversed (Figure 5). In BPD FPCs, in contrast,
such asymmetries were somewhat less obvious, differing somewhat
from those of SCH in the densities of 7-AAD(+) and NeuN(+)
nuclei (Figure 5).
There is a body of anatomical evidence suggesting that SCH is
associated with disturbances in cerebral asymmetry [31]. Based
largely on neuroimaging studies, the reported abnormalities in
hemispheric asymmetry in SCH include a lack of normal
asymmetry [32], less than normal asymmetry [33], and a reversal
of normal asymmetry [34-36]. At the cellular level, however, the
results remain mixed, partly due to various methodological
problems associated with conventional histopathology as described
above. Only Cullen et al. reported asymmetry anomalies in
A Postmortem Brain Study for Psychiatric Disorders
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of DLPFCs from SCH patients. Although they used conventional
paraffin sections, tissue shrinkages during the embedding process
were measured and matched between groups [37].
Although caution is still required when interpreting our data
(e.g., the sample size was small when divided into hemispheres,
and tissue from only one hemisphere was available from each
subject in the present study), this is the first quantitative cell-
counting report demonstrating the presence of left-greater-than-
right asymmetries in the neural nuclei densities from the gray
matter of control FPCs and their significant reversal in the gray
matter of SCH FPCs. These findings are also strongly consistent
with the above-mentioned gross anomalies that are typically found
in SCH samples [31-36]. Considering the fact that most
neuropathological studies have focused on only one (usually the
left) hemisphere, future studies should utilize the brain collection in
order to fully investigate the true laterality of the neural nuclei
densities found in the human brain.
In conclusion, our FCM studies provide comprehensive
evidence that these major psychiatric disorders do share similar
neuropathological abnormalities. On the other hand, we also
found certain neuropathological differences mainly in the FPC. If
we take into account the fact that neurogenesis is almost
exclusively restricted to early development [38], our findings
suggest that the disturbances in NeuN(+) nuclei commonly
observed in psychiatric disorders may occur over multiple stages
of early brain development. In addition, disturbances in adulthood
cortical myelination may also play a role in the origin of mood
disorders. These disturbances may be influenced, to different
extents, by genetic and/or environmental factors. Our innovative
method could thus serve as a useful tool for future research, not
only for the enhanced quantitative determinations of glial and
interneuron subtypes in the human brain, but also for the study of
animal models under varying degrees and conditions of genetic
and environmental stress.
Materials and Methods
All experimental protocols were approved by the Ethics
Committee of the Tokyo Metropolitan Institute of Medical
Science.
Postmortem human brains
Frozen brain blocks from the FPC (BA10) and ITC (BA20) were
generously provided by the Stanley Foundation Brain Collection
(The Stanley Medical Research Institute, Bethesda, MD). Brain
blocks were dissected from the lateral aspect of the frontal pole and
from the gyral surface of the inferior temporal gyrus as described
in the original paper by Brodmann [39]. The entire gray matter,
from the surface to the border between layer VI and the white
matter, was carefully dissected out manually from the frozen
blocks with a sharp blade. About 20 mg of gray matter was
collected from each specimen. The original collection consisted of
15 control, 15 BPD, and 15 SCH brains. Psychiatric diagnoses had
been established by two psychiatrists using DSM-IV, medical
records evaluations, and telephone interviews with family
members, and were further examined by the Stanley Foundation
review committee. We excluded 11 FPC and 11 ITC samples
because they lacked entire gray matter layers as a result of previous
experiments. We then analyzed the remaining samples (FPC, 12
control, 12 BPD, 10 SCH; ITC, 12 control, 11 BPD, 11 SCH).
Demographic data on the brains included in this analysis are
provided in Table S1. Ten out of 12 BPD subjects (FPC samples)
and 8 out of 11 BPD subjects (ITC samples) had exhibited
psychotic behavior. Other information about these brains has been
described previously [40].
In all cases, the Stanley Medical Research Institute obtains
written next-of-kin permission prior to using brains for research
purposes. A detailed description of the Stanley Brain Collection
can be obtained from the Institute’s website at www.
stanleyresearch.org.
Nuclei isolation and FCM measurements
Tissue samples were processed and the counting, immunostain-
ing, and FCM measurements of nuclei were performed as
described by Hayashi et al. [16]. Briefly, a crude suspension of
nuclei was obtained through mechanical homogenization of the
brain tissue (1 min) in a 10-fold volume of lysis buffer (V/W)
(0.32 M sucrose, 5 mM CaCl2, 3 mM magnesium acetate,
0.1 mM EDTA, 10 mM Tris-HCl [pH 8.0], 0.1% Triton X-
100, osmolality ,375 mOsm) using a set of plastic homogenizers.
We chose this lysis buffer and homogenizers because Herculano-
Houzel and Lent [41] had reported that when utilizing their
isotropic fractionator method they were unable to obtain intact
nuclei from unfixed brains (see Figure 1 in ref. [41]), which
probably stemmed the use of an unsuitable lysis buffer with
relatively high hypo-osmotic pressure (approximately 80 mOsm).
The dissolved nuclei were centrifuged and then quickly suspended
in PBS (280 mOsm) containing the fluorescent DNA marker 7-
AAD (BD Pharmingen, Franklin Lakes, NJ). From this point on,
nuclei were continuously suspended in solutions of 280 –
290 mOsm until FCM measurement in order to preserve nuclear
size and structure. An aliquot of the 7-AAD stained nuclei was
mixed with an equal amount of Flow-CountH (Beckman Coulter,
Fullerton, CA) prior to calculating the total nuclear number by
FCM (Epix XL, Beckman Coulter, Fullerton, CA). IsoFlowtm
(290 mOsm) (Beckman Coulter, Fullerton, CA) was used as the
sheath fluid. Once the total nuclei number was known, the
proportion of neuronal and oligodendroglial nuclei was deter-
mined by immunocytochemical detection of the neuronal nuclear
marker NeuN (Chemicon, Temecula, CA) and by the pan-
oligodendroglial cell marker olig2 (Chemicon), respectively. Each
absolute nuclear density was calculated by multiplying the number
of total nuclei by each nuclear proportion. To investigate the
stability of isolated nuclei, FCM measurements were performed
4 h or 18 h after homogenization and the resulting FS values for
each nuclei were then compared.
A comparison of human NeuN(+) nuclei size using visual
and FCM measurements
The human samples (n=2) were homogenized and then stained
with NeuN and 7-AAD. The stained nuclei in PBS (280 mOsm)
were dropped onto glass slides, overlaid with coverslips, and then
observed under a fluorescent microscope (BX51; Olympus, Tokyo,
Japan). Individual nuclear areas positive for NeuN or 7-AAD were
traced and acquired with Image J software (available at http://rsb.
info.nih.gov/nih-image). A total of two hundred NeuN(+) and 7-
AAD(+) neuronal nuclei profiles were measured and analyzed.
The same samples were also analyzed with FCM. The distribution
of NeuN(+) nuclei FS values was plotted and compared with those
of the 7-AAD(+) and NeuN(+) nuclei areas obtained by
microscopic measurements.
Animal studies
All experimental animal protocols were approved by the Animal
Use and Care Committee of the Tokyo Metropolitan Institute of
Medical Science.
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maintained in a temperature-controlled room (,23uC) with a
12 h/12 h light/dark cycle, in accordance with the Animal Use
and Care Committee guidelines of the Tokyo Metropolitan
Institute of Medical science. Experiments were performed during
the light period. Eight-week-old rats (male, n=8; female, n=4)
were killed with a lethal dose of anesthesia (pentobarbital sodium),
and were then perfused with phosphate-buffered saline (PBS)
containing 50 IU/ml heparin. The brains were then removed
from the skull, and the cerebral cortex was dissected out as
described by Herculano-Houzel and Lent [41]. The brains were
immediately frozen and stored at 280uC until measurements were
carried out. The frozen brains were used within a month, except
for a group of brains from 8-week-old rats (n=4), which were
stored for 385 days in order to investigate the effects of frozen
storage.
To determine the effects of postmortem intervals (PMIs), rats (8-
week-old, male, n=4) were killed by either a lethal dose of
anesthesia or by cervical dislocation. The animals were then kept
at 4uC for 0, 24, or 48 h without perfusion. At each PMI, brains
were removed from the skull, the cerebral cortex was dissected out
as described above, and the tissue was immediately frozen and
stored at 280uC until measurements were conducted. These
samples differed from the perfused samples in that they contained
blood cells.
Each brain region was homogenized and their nuclei content
measured as described above. Gender, frozen storage days, and
PMIs had no significant effects on the absolute numbers of nuclei
in the whole rat cerebral cortex (Figure S3).
For a comparison of the FS distributions of NeuN(+) nuclei, we
chose two FS ranges (FS101-FS199 and FS251-FS349) and
performed an unpaired t-test.
Statistical analysis
Statistical analyses were carried out using GraphPad
PRISM
TM software (Graph Pad software, Inc., San Diego,
CA) and SPSS
TM (SPSS, Inc., Chicago, IL). To compare the
numbers of nuclei in the psychiatric and control groups, we used
an unpaired t-test. In order to determine whether countable
confounding factors contributed significantly to the variances in
the FCM measurements, we first performed Pearson’s correla-
tions between the nuclei density of each cell type and the
following factors: age at death (years), refrigeration interval (h),
PMI (h), pH, weight (gram), and duration of frozen storage. Age
at onset (years), duration of disease (years), Fluphenazine
equivalent (mg) were studied separately due to a lack of control
variables. The nuclei density was then compared between
groups using analysis of covariance (ANCOVA) for any
variables that contributed a significant proportion of variance
to the FCM measurements. The effects of non-continuous
confounding variables (gender, hemisphere, and severity of
alcohol and/or substance abuse) on nuclei density were assessed
using an unpaired t-test. To analyze size differences in the
NeuN(+) nuclei, we divided the NeuN(+) nuclei population into
subpopulations with forward scatter (FS) values (n , n+99,
where n ranged from 100 to 300 at intervals of 10) and analyzed
all of the subpopulations with an unpaired t-test. In order to
match certain confounding factors, such as the refrigeration
interval and PMI between groups, we excluded samples with
extremely long refrigeration intervals (. 20 h) and PMIs (.
40 h), and then reanalyzed the rest of the samples vis-a `-vis the
nuclei densities and sizes. When analyzing brain asymmetry, we
used two-factor factorialA N O V A( d i a g n o s t i cg r o u p 6brain
hemisphere).
Supporting Information
Figure S1 Microscopic measurements of isolated nuclei
size. (A) 7-AAD(+), (B) NeuN(+) nuclei in PBS (280 mOsm)
prepared from unfixed frozen human cortical tissue. (C) A merged
image. Scale bar, 25 mm. (D) A traced image of 7-AAD(+) nuclei in
panel A by Image J. (E) A traced image of NeuN(+) nuclei in panel
A by Image J.
(TIF)
Figure S2 Effects of confounding factors on the FS
distribution of NeuN(+) nuclei from rat cerebral corti-
ces. (A) Effect of gender. No significant difference was found in
the FS distribution of NeuN(+) nuclei between males (blue) and
females (red) (unpaired t-test, FS100-199, t(6)=-1.081, P=0.321;
FS250-349, t(6)=1.134, P=0.300). (B) Effect of frozen storage. No
significant difference was found in the FS distribution of NeuN(+)
nuclei at 20 (blue) or 385 days (red) (unpaired t-test, FS100-199,
t(6)=-0.265, P=0.800; FS250-349, t(6)=0.498, P=0.636). (C)
Effect of PMI. Brains were dissected out at 0 (blue), 24 (red), and
48 (green) h after the rats were sacrificed. With increasing PMIs,
the FS distribution peaks of the NeuN(+) nuclei shifted towards
larger FS values. No significant difference was found in small
NeuN(+) nuclei (unpaired t-test, FS100-199, F(2,9)=3.132,
P=0.093), while a significant difference in the large NeuN(+)
nuclei was noted (FS250-349, F(2,9)=13.441, P=0.002).
(TIF)
Figure S3 Effects of confounding factors on the absolute
nuclear numbers in the whole rat cerebral hemisphere.
Total (blue), NeuN (red), olig2 (green), and NeuN(2)/olig2(2)
(purple) nuclei numbers in the whole rat cerebral hemisphere
(610
6 cells/brain, 8 month-old) are shown. (A) Effect of PMI. PMI
exerted no significant effect on any of the nuclei numbers (one-way
ANOVA, total, F(2,9)=0.48, P=0.633; NeuN(+), F(2,9)=0.98,
P=0.412; olig2(+), F(2,9)=0.33, P=0.727; NeuN(2)/olig2(2),
F(2,9)=1.99, P=0.193). (B) Effect of frozen storage. Duration of
storage (days) had no significant effect on any of the nuclei
numbers (unpaired t-test, total, t(6)=-0.094, P=0.928; NeuN(+),
t(6)=0.140, P=0.893; olig2(+); t(6)=-1.764, P=0.128; NeuN(2)/
olig2(2); t(6)=1.106, P=0.311). Data represent mean6s.d. Note
that these findings suggest that neither PMIs nor frozen storage
reduce the immunoreactivities of NeuN or olig2 to any significant
degree.
(TIF)
Table S1 Demographic data of individuals from whom FPC and
ITC samples were obtained.
(DOC)
Table S2 Statistical results of the FS distribution of NeuN(+)
nuclei by unpaired t-test.
(DOC)
Table S3 Correlation between each nuclei number and the
confounding factors (Part I).
(DOC)
Table S4 Correlation between each nuclei number and the
confounding factors (Part II).
(DOC)
Table S5 Statistical results of nuclei densities in the FPC or ITC
from the selected subjects excluding those with longer refrigeration
intervals (. 20 h) and PMIs (. 40 h).
(DOC)
Table S6 Statistical results of the FS distribution of NeuN(+)
nuclei in the FPC or ITC from the selected subjects, excluding
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33019those with longer refrigeration intervals (. 20 h) and PMIs (.
40 h).
(DOC)
Table S7 Effects of gender, hemisphere, and substance and/or
alcohol abuse on each nuclei density in FPC gray matter.
(DOC)
Table S8 Effects of gender, hemisphere, and substance and/or
alcohol abuse on each nuclei density in ITC gray matter.
(DOC)
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